Introduction: Maternal depression (MD), is an overarching term for depression affecting pregnant women and mothers for up to 12 months postpartum. Because MD may have chronic and long-lasting effects, it is an important public health concern. The extent to which telemedicine may be an effective way to provide services to sufferers of MD is unknown, therefore, this review aimed to assess the available evidence. Methods: We conducted a search of The Cochrane Library, PubMed/MEDLINE, PsycINFO, and EMBASE for relevant randomised controlled trials published between 2000 and 2018; we then conducted a systematic review and meta-analysis. Results: We identified 10 studies for inclusion. Therapeutic strategies involved cognitive behavioural therapy (CBT), behavioural activation and other psychoeducation. Eight trials reported significant improvement in depression scores post-intervention; four studies that conducted post-intervention follow-up found that these improvements continued. However, high attrition rates and lack of blinding were common problems. Discussion: This review found limited evidence supporting the delivery of CBT for the treatment of MD and anxiety using telemedicine. However, most of the evidence only studied improvements in postpartum depression, indicating that use of telemedicine to provide MD intervention is still small and an under-researched area.
Introduction
The period surrounding pregnancy and childbirth can increase the risk of maternal depression (MD), which is driven by social, psychological and biological changes. 1 MD, which encompasses antenatal, perinatal, postnatal and postpartum depression, is a common cause of maternal morbidity following childbirth. 2 Poor screening rates, late or misdiagnosis, and reluctance to seek help due to stigma or embarrassment are some of the main issues relating to MD treatment. 1 Studies have shown that previous MD leads to depression relapse. 3 Effects of MD include disengaged maternal behaviour, impaired mother-infant relationships, as well as passive, withdrawing and self-regulatory behaviour in the infant. [3] [4] [5] This has been linked to long-term attachment, emotional development and social difficulties in children extending to adolescence. 3 Child abuse or neglect, and separation or divorce due to marital stress have also been reported as 1 School of Public Health, The University of Queensland, Australia 2 Centre for Online Health, The University of Queensland, Australia 3 Centre for Clinical Research, The University of Queensland, Australia 4 Centre for Health Services Research, The University of Queensland, Australia consequences. 3 In serious cases, maternal and infant mortality can result from MD. 3 Globally, MD is a priority within the Millennium and Sustainable Development Goals. 2 In Australia, MD rates averaged 9% in early pregnancy, 8% in the first trimester, 10% in the first year and 11% at 18-months postpartum. 6 However, research shows that the incidence of MD may be heavily underreported and that the economic burden associated with treatment may be underestimated. 6 Evidence-based approaches to addressing MD include psychotherapy, counselling and family therapy -all of which require face-to-face sessions with the patient/family and practitioner. [7] [8] [9] With MD being a mental health issue within a vulnerable population, psychotherapy is commonly used as treatment as it focuses on improving social support and is not medication-based. 10, 11 Telemedicine may be an effective means of delivering evidence-based interventions for MD. Due to the acute and relapsing nature of MD, effective means of treatment are required. However, the extent to which telemedicine may able to provide services to sufferers of MD is unknown. Therefore, this review aimed to assess current knowledge and systematically review the evidence to inform future research.
Methods
We searched for randomised controlled trials (RCTs) published from January 2000 to April 2018 in The Cochrane Library, PubMed/MEDLINE, EMBASE, and PsycINFO. We conducted a search and reported it using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ( Figure 1 ) 12 and a condensed search strategy (Table 1) . Studies were excluded if they sampled women with unsuccessful pregnancies, did not list depression as a main measurable outcome and/or did not include a telemedicine intervention. A title and abstract search were performed, and relevant information extracted and tabulated by the first author (UN, Table 2 ). This information was reviewed independently by a second author (SE). The quality of evidence was assessed independently via the Joanna Briggs Institute Critical Appraisal Checklist for RCTs (JBI) ( Table 3) . Any discrepancies were solved through discussion until consensus was reached. This review was registered in Figure 1 . Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart. 12 the International Prospective Registry of Systematic Reviews (PROSPERO: CRD42018093123-9/5/2018). 13 
Results
The search identified 4654 articles, of which ten RCTs conducted between 2013 and 2018 met the criteria for review ( Table 2 ). The search process is shown in Figure 1 .
Study characteristics
Sample sizes ranged between 42 14 and 852; 15 four studies had a sample size ! 100. The studies represent 1138 women (age 26.3-32.6 years). All studies were conducted in developed countries (United States, Singapore, United Kingdom, Sweden, Australia, and Canada). Studies recruited women from the postnatal, 16, 17 perinatal, 18, 19 antenatal populations 14, 20 , and postpartum periods. 15, [21] [22] [23] Eight studies recruited via self-referral and two used physician referral. 20, 23 Four studies had post-intervention follow-up for 1-9 months with improvements in MD symptoms favouring the treatment group. 15, [20] [21] [22] Interventions Eight studies targeted treating, while two targeted preventing MD symptoms. 15, 19 Therapeutic strategies mainly utilised cognitive behavioural therapy 14, 15, 17, 19, 20, 22 , although behavioural activation 16, 21 , unspecified psychoeducation 23 and mood tracking were also included. 18 Additionally, five studies involved therapist contact via face-to-face, 23 telephone calls 14, 17, 21 or email. 22 Seven studies had treatment as usual control groups, 14, [16] [17] [18] 20, 21, 23 one used a waitlist, 22 and two used comparator groups. 15, 19 Delivery methods
All studies used more than one mode of telemedicine, including traditional telephone calls, email and smartphone applications, although most used websites.
Only one study utilised telemedicine in real-time with Internet clinics via chatrooms. 16 Most studies utilised websites as a means of delivering interventions via prestructured sessions.
Telephone calls were utilised in seven studies, 14, [16] [17] [18] [21] [22] [23] for measurement 14, 17, 21 , telephone coaching 17, 21 and follow-up. 16, 18, [21] [22] [23] Email was used in six studies for monitoring 15, 16, 19, 21 , support and encouragement 21, 22 , recruitment, 17,21 delivery of intervention materials, 19 or as a reminder system. 16, 17, 21 Traditional telephone calls were not used in any studies as a mode of intervention but were used as a means of supplementing telemedicine use.
Only two studies utilised smartphone applications. 18, 23 The first provided psychoeducation via role-specific education, push notifications and asynchronous communication with healthcare professionals. 23 The second implemented a smartphone moodtracking application with and without incentive. 18 Both studies supplemented the smartphone application with traditional telephone calls.
Study outcomes
In all the studies, effectiveness was measured using clinical outcomes, although a variety of scales were used. The effect of telemedicine significantly improved MD outcomes in 80% of studies. 14, [16] [17] [18] [19] [20] [21] [22] Similarly, telemedicine interventions significantly improved anxiety outcomes in 75% of studies that measured the outcome. 14, [17] [18] [19] 22, 23 Quality of evidence Sample sizes were between 42 14 and 852 15 but only four studies had a sample size over 100. Quality of evidence in these studies varied considerably. In many papers, sampling bias due to self-referral recruitment was present and outcomes were not consistently reported. However, all studies reported their demographics and trials adequately. Although attrition rates ranged from 9.7% to 78.9%, most studies reported a low risk of bias due to incomplete data as outcomes were reported in a pre-specified manner in all studies.
Meta-analysis
Because of differences between the selected studies, a meta-analysis of all studies was deemed inappropriate. However, a meta-analysis of studies that used the Edinburgh Postnatal Depression Scale (EPDS) generated a forest plot to examine if potential generalisations provided a more comprehensive overview (Figure 2 ). 24 The meta-analysis indicated heterogeneity (I 2 ¼ 74.2%; X2 = 14.63; df ¼ 4; p ¼ 0.06). Effect sizes ranged between À0.69 and À4.03. 23 Sources of heterogeneity are likely differences in outcomes 19, 23 and follow-up time.
14,16,21,22
Discussion
The focus in telemedicine research appears to have changed from technical-related applications to clinical use and evaluation. 25 Where the research interest was once on technology and systems, there has been an observable change towards a patient-and illnesscentred focus. However, the appropriateness of implementation of telemedicine is often poorly informed or uninformed. 26 A formal analysis of telemedicine implementation could identify appropriate patients, conditions and settings. 27 Therefore, there is a need for a high-quality evidence-base to support uptake and sustainable integration of telemedicine into routine clinical care. 26 This study aimed to provide a systematic analysis of current literature so as to inform future research. 27 Consistent with previous reviews of a similar nature, we found that most reported significantly improved MD and anxiety outcomes, although most of the included studies in this review were small. 1, 28 However, two studies reported poorer outcomes in their treatment group, which used a smartphone application to deliver psychoeducation tracking and a website to deliver cognitive behavioural therapy (CBT). Therefore, definite conclusions about the effectiveness of using telemedicine to deliver MD treatments could not be drawn. However, it sheds light on the complex nature of MD and its confounders, 19, 23 which is an important consideration in future studies.
This review found that a common telemedicine intervention was website-use and the main therapeutic device was CBT. Although smartphone applications were also reported, there was a lack of evidence supporting the use of telemedicine with medical devices. Another key finding of this review was improved depression outcomes in severely depressed patients in the studies by O'Mahen et al. and Hantsoo et al., highlighting the differences between severe and moderate depression. 16, 18 Milgrom et al. showed a doseresponse improvement in depression scores with the number of telemedicine treatment sessions attended among the intervention group, even at the 9-month follow-up. 20 However, we must also consider that most studies used self-report questionnaires instead of therapist assessments, which introduced bias in this review.
High attrition rates are a common issue in telemedicine trials affecting result validity. 16, 21, 22 In this review, early attrition rates were generally lower and comparable between studies, although they increased with time.
Because of the small number of trials and the diversity of interventions including therapies, it is difficult to draw definite conclusions about telemedicine effectiveness. Furthermore, all the trials were in developed countries, affecting the applicability of the results in developing countries and highlighting a gap in current knowledge. Although the systematic search identified several other related trials in developing countries, they were excluded due to study characteristics. The participant age group involved in all the studies were similar, affecting generalisability. Trials surrounding adolescent pregnant women have been conducted, exemplifying the current interest and rapid development in this field, but more research is required. 29 Direct comparison of findings was difficult due to differing populations and stages of pregnancy between the trials. Furthermore, trials eligible for subgroup meta-analysis were relatively low, limiting statistical power. These limitations can inform future metaanalytic reviews.
Although the studies had different outcome measures that constrained meta-analysis, overall findings support telemedicine use for improved MD outcomes. Furthermore, studies that conducted post-intervention follow-up reported continued positive effects on reducing MD. Long-term outcomes are important for future evaluation as depressed patients have a higher risk of relapse. 30 Finally, as only RCTs were included, there was a low risk of bias for participant randomisation. However, selection bias could not be avoided as only five studies achieved sufficient allocation concealment. Furthermore, only three studies achieved participant blinding and blinding of treatment conditions was not possible in half the studies, performance and detection bias are likely ( Table 3) .
Strengths of this review were a clear systematic search, study selection and review protocol, the inclusion of RCTs, and adherence to the PRISMA methodology and guidelines. There were several limitations, including the small number of trials (n ¼ 10) and variation in measurement scales and time points. These reasons coupled with the lack of consistent outcome reporting affected our ability to quantify results. Furthermore, self-referral recruitment introduced sampling and reporting bias. 14, 20, 22 Five studies had a small or moderate sample size 14, 15, 17, 20, 22 which could have caused inflated effect sizes. Although two studies reported poorer intervention effect on MD, there is potential underreporting of negative trials leading to further publication bias. 19, 23 Alternatively, trials that reported negative consequences may have been conducted but not yet published or formally evaluated, and therefore were excluded from this review.
Conclusion
A formal review of current evidence assessing telemedicine effectiveness for treating MD has not been conducted until now. Telemedicine is promising due to its versatility, non-invasive nature and the increasing global everyday prevalence of the Internet and communication devices. We found that interventions delivered via telemedicine have been shown to effectively alleviate MD symptoms, improving treatment efficacy. Although meta-analysis did not report adequate homogeneity between the selected studies, there is evidence of some correlation between telemedicine interventions and improvement in MD. As the literature in this field improves, it is desirable to re-evaluate this homogeneity.
This review highlights a number of directions for future research, including attention for antenatal and peripartum depression, utilising bi-directional communication to establish a relationship between participants and researchers, and applicability across adolescent mothers.
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